UPDATE 1-Vir, Alnylam identify COVID-19 therapy candidate, plan human trials by year end
May 04, 2020 at 08:20 AM EDT
Vir Biotechnology Inc and Alnylam Pharmaceuticals Inc have identified a drug candidate for treating COVID-19 and plan to begin human testing by the end of the year, the companies said on Monday.